Coronary disease & ACSCross-sectional study
Risk-factor control and secondary prevention in ischaemic heart disease in primary care: real-world insights from QregPV
- Cross-sectional study
- regional primary-care register
Authors' conclusion
Combined risk-factor control was low, largely due to low LDL-C control, despite high LLT usage. Risk-factor control and the use of LLT and ATT varied between PHCCs and were lower in women than men.
Study context
- Population
- Ischaemic heart disease (IHD) patients in Swedish primary care (QregPV), September 202334.5% women
- Participants
- 45,771 patients
- Outcome
- Combined risk-factor control (BP <140/90 mmHg, LDL-C < 1.4 mmol/L, non-smoking)
Main finding
Combined risk-factor control
Adjusted odds ratio
0.60
CI 0.55–0.66
Women vs Men
aOR 0.60 (CI 0.55–0.66)
As reported in the abstract
- Combined risk-factor control
- 15.5% (95% CI 15.0-16.0)
- Decreased with higher age
- P < 0.001
Observational data: associations, not effects.
Further findings
| Outcome | aOR (CI) | |
|---|---|---|
| LLT use | 0.52 (0.50–0.54) | |
| ATT use | 0.58 (0.54–0.62) | |
| 0.512Adjusted odds ratio (log scale) |
- Lipid-lowering therapy (LLT) use — LLT use (76.8-77.6)
- 77.2%
- Antithrombotic therapy (ATT) use — ATT use (85.2-85.9)
- 85.6%
LDL-C attainment (< 1.4 mmol/L)
- LDL-C attainment (20.3-21.1)
- 20.7%
Heterogeneity among primary health care centres (PHCCs) in combined risk-factor control
- Adjusted median OR (adjusted median odds ratios (aMOR)) (1.32-1.48)
- 1.39
Original publication
Risk-factor control and secondary prevention in ischaemic heart disease in primary care: real-world insights from QregPV. Eur J Prev Cardiol. Published 7 February 2025. doi:10.1093/eurjpc/zwaf052
Summarised from the published abstract; every number is checked against it